BTC$58,525.00-2.87%
ETH$1,566.72-2.66%
USDT$0.9985-0.02%
USDC$0.9996-0.01%
BNB$544.90-2.56%
XRP$1.04-1.83%
SOL$73.31-2.61%
TRX$0.315-1.87%
FIGR_HELOC$1.01-3.51%
HYPE$64.60-3.63%
DOGE$0.0718-2.19%
RAIN$0.0157-1.31%
USDS$0.9995-0.01%
LEO$9.26-3.16%
ZEC$394.57-3.26%
WBT$53.93+12.53%
BTC$58,525.00-2.87%
ETH$1,566.72-2.66%
USDT$0.9985-0.02%
USDC$0.9996-0.01%
BNB$544.90-2.56%
XRP$1.04-1.83%
SOL$73.31-2.61%
TRX$0.315-1.87%
FIGR_HELOC$1.01-3.51%
HYPE$64.60-3.63%
DOGE$0.0718-2.19%
RAIN$0.0157-1.31%
USDS$0.9995-0.01%
LEO$9.26-3.16%
ZEC$394.57-3.26%
WBT$53.93+12.53%
Amazon’s latest outage exposed its systemic importance: when the internet falters, the market still bets on AWS.
Beyond Meat stock jumped more than 60% after announcing a nationwide Walmart expansion, including the launch of its new value-priced Beyond Burger 6-Pack.
GM stock jumped more than 10% after the company raised its full-year guidance and cut its 2025 tariff cost estimate to $3.5–$4.5 billion from $4–$5 billion.
Rocket Lab stock rose 2.7% in premarket trading after announcing its sixth iQPS satellite launch, reinforcing its growing role in the small satellite market.
Despite tariff shocks and market jitters, 2025 is shaping up as the strongest year for IPOs since the liquidity boom of 2021.
Archer stock rose over 4% after announcing a partnership with Korean Air to launch electric air taxis in South Korea.
Cleveland-Cliffs stock jumped over 17% after announcing plans to expand into rare earth production at U.S. mining sites.
Robinhood stock has surged 250% in 2025, fueled by its S&P 500 debut and rapid growth across new fintech ventures.
Cooper stock jumped over 6% premarket after Jana Partners took a stake and called for a strategic review.
Oracle shares fell over 7% despite a new Meta partnership, as investors focused on rising costs and execution risks.
As First Brands’ bankruptcy unravels, signs point to a deeper collateral risk brewing across mid-sized lenders.
Artiva Biotherapeutics skyrocketed today after receiving FDA Fast Track status for its AlloNK therapy in refractory rheumatoid arthritis.
Eli Lilly shares fell over 3% in premarket trading after Trump signaled price cuts for weight loss drugs, sparking concerns over future margins.